Skip to search formSkip to main contentSkip to account menu

ABT-089

Known as: A-87089.0, ABT 089, ABYT 089 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Levodopa‐induced dyskinesias (LIDs) are a serious complication of levodopa therapy for Parkinson's disease for which there is… 
Highly Cited
2008
Highly Cited
2008
Because modulation of cortical cholinergic neurotransmission has been hypothesized to represent a necessary mechanism mediating… 
Review
2004
Review
2004
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride salt] is a selective neuronal nicotinic receptor (NNR… 
Highly Cited
1998
Highly Cited
1998
Abstract Increased distractibility is associated with both Alzheimer’s disease and attention deficit disorder. The present study… 
Highly Cited
1998
Highly Cited
1997
Highly Cited
1997
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride], a novel ligand at neuronal nicotinic acetylcholine… 
Highly Cited
1997
Highly Cited
1997
Accumulating preclinical and clinical evidence data suggests that compounds that selectively activate neuronal nicotinic…